The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 – A formulator’s perspective
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference71 articles.
1. National health systems and COVID-19 death toll doubling time;Alfaro;Front. Public Health,2021
2. A comprehensive look at the COVID-19 pandemic death toll;Simonsen;ELife,2021
3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res.,2020
4. Comprehensive analysis of drugs to treat SARS-CoV-2 infection: mechanistic insights into current COVID-19 therapies (review);Nitulescu;Int. J. Mol. Med.,2020
5. Minimum manufacturing costs, national prices, and estimated global availability of new repurposed therapies for coronavirus disease 2019;Wang;Open Forum Infect. Dis.,2022
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in encapsulation of resveratrol for enhanced delivery;Food Chemistry;2024-12
2. Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention;Current Reviews in Clinical and Experimental Pharmacology;2024-11
3. Enhancing bioavailability of resveratrol through complexation with π-acceptors: A spectroscopic investigation;Journal of Molecular Structure;2024-11
4. Biotechnological approaches in the production of plant secondary metabolites for treating human viral diseases: Prospects and challenges;Biocatalysis and Agricultural Biotechnology;2024-07
5. A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma;Current Molecular Medicine;2024-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3